Cone-Rod Disease (C-RD): Clinical Trials

1 trial for Cone-Rod Disease (C-RD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Cone-Rod Disease (C-RD): new trials by email Literature Review of Cone-Rod Disease (C-RD) trials Research Report on Cone-Rod Disease (C-RD)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
OpCT-001 - Primary Photoreceptor Disease, Retinitis Pigmentosa (RP)
Phase 1 / Phase 2RecruitingBlueRock Therapeutics542025-03-102026-10-15

Narrower conditions

Cone-Rod Dystrophies (1)  ·  Retinal Degeneration (1)  ·  Retinitis Pigmentosa (1)  ·  Usher Syndromes (1)

Broader conditions

Abnormalities, Multiple (1)  ·  Blindness (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Deaf-Blind Disorders (1)  ·  Deafness (1)  ·  Ear Diseases (1)  ·  Eye Diseases (1)  ·  Eye Diseases, Hereditary (1)  ·  Genetic Diseases, Inborn (1)  ·  Hearing Disorders (1)  ·  Hearing Loss (1)  ·  Hearing Loss, Sensorineural (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)

Sponsors

BlueRock Therapeutics (1)

Countries

United States (1)